Early data suggest Roche’s NXT007 may have the potential to - GlobeNewswire
  [Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidysâ„¢ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients - Roche
  Roche: positive Phase I/II data in hemophilia A - MarketScreener
  Early data suggest Roche's NXT007 may have the potential to prov - GuruFocus
  Roche, waving off study failures, commits to Phase 3 trials for Parkinson’s drug - BioPharma Dive
  Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short - Fierce Pharma
  Man sentenced to prison for distributing PCP in baby bottles in DC's Petworth neighborhood - WUSA9
  Roche, Prothena Push Parkinson’s Drug to Phase III Despite Mid-Stage Fail - BioSpace